Membership
Tour
Register
Log in
97650790 - MORPHABOND · ER (MORPHINE SULFATE) EXTENDED-RELEASE TABLETS
Follow
Information
Trademark
97650790
Source
Serial Number
97650790
International Classifications
5 - Pharmaceutical and veterinary preparations
Filing Date
October 27, 2022
2 years ago
Transaction Date
November 30, 2023
a year ago
Status Date
November 30, 2023
a year ago
Location Date
November 30, 2023
a year ago
Status Code
602
Current Location
TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED
Employee Name
MAJCHER HARTNETT, MEGA
Attorney Docket Number
Ohemo-MorphB
Attorney Name
William E. Beaumont
Law Office Assigned Location Code
N50
Owners
OHEMO Life Sciences Inc.
Information
Content
Industries
Organizations
Transactions
Events
Timeline
Mark Drawing Code
5000
Mark Identification
MORPHABOND · ER (MORPHINE SULFATE) EXTENDED-RELEASE TABLETS
Case File Statements
DM0000: The mark consists of Morphabond ER (morphine sulfate) extended release tablets with stylized C II.
GS0051: Preparation for the relief of pain
CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
11/30/2023 - a year ago
9 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type:
MAB2
11/30/2023 - a year ago
8 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Type:
MAB2
11/30/2023 - a year ago
7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type:
ABN2
8/16/2023 - a year ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type:
GNRN
8/16/2023 - a year ago
5 - NON-FINAL ACTION E-MAILED
Type:
GNRT
8/16/2023 - a year ago
4 - NON-FINAL ACTION WRITTEN
Type:
CNRT
8/10/2023 - a year ago
3 - ASSIGNED TO EXAMINER
Type:
DOCK
11/10/2022 - 2 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type:
NWOS
10/31/2022 - 2 years ago
1 - NEW APPLICATION ENTERED
Type:
NWAP